CoChat
Sign Up
Cited by 1,004Blood Pressure and Hypertension StudiesChronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

National High Blood Pressure Education Program Working Group report on hypertension in diabetes

Open access
·1994·Hypertension
DOI 10.1161/01.hyp.23.2.145
Open this paper in CoChat — free accountOpen PDF

Abstract

Hypertension and diabetes mellitus are interrelated diseases that, if untreated, strongly predispose to atherosclerotic cardiovascular disease and renal disease. More than 3 million Americans have both hypertension and diabetes, which are particularly prevalent in the socioeconomically disadvantaged. Hypertension contributes substantially to morbidity and mortality in people with diabetes. This report is an update of the 1987 working group report on hypertension and diabetes and includes important new information on the management of hypertension in people with diabetes. Although treatment of hypertension in most people with diabetes does not differ from that in people who do not have diabetes, this report outlines some special considerations relevant to the presence of both diseases. Lifestyle modification is considered as an initial treatment modality or as an adjunct to pharmacologic measures. This report also includes a discussion of the treatment of hypertension and diabetes in children, an expanded review of sexual dysfunction, and an increased emphasis on the effect of hypertension and diabetes on target organs. A treatment algorithm represents a practical guideline for the physician. Since the previous report, there has been an increased awareness, through clinical trials and pharmacologic research, of the importance of flexibility in the use of antihypertensive drugs as well as a refinement of nonpharmacologic approaches in treating people with both hypertension and diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.23.2.145

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hypertension is a common comorbidity affecting more than 60% of individuals with type 2 diabetes.

    “Hypertension is a common comorbidity affecting more than 60% of individuals with type 2 diabetes ( 201 , 249 ).”

    From Exercise and Type 2 Diabetes (2010) · cites this paper as [201]

    The introductory passage supports that hypertension is common in people with diabetes, stating that it is approximately twice as common as in people without diabetes. It does not establish that more than 60% of people with type 2 diabetes have hypertension. Its figure of more than 90% refers instead to the proportion of people with both diagnoses who have type 2 diabetes. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. National Diabetes Data Group. Summary. In: Harris MI, Hamman RF, cds. Diabetes in America. Washington, DC: GPO; US Dept of Health and Human Services, NIH publication 85-1468; 1985:1-16.
  2. Working Group on Hypertension in Diabetes -National High Blood Pressure Education Program. Statement on hypertension in diabetes mellitus: final report. Arch Intern Med. 1987;147: 830-842.
  3. Horan M. Diabetes in hypertension. In: Harris MI, Hamman RF, eds. Diabetes in America. Washington, DC: GPO; US Dept of Health and Human Services, NIH publication 85-1468; 1985: 17-18. Diabetes data compiled 1984.
  4. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?/)rc/i Intern Med. 1989;149:2427-2432.
  5. American Diabetes Association. Consensus statement on the treatment of hypertension in diabetes. Diabetes Care. 1993;16: 1394-1400.
  6. Dawson KG, McKenzie JK, Ross SA, Chiasson J-L, Hamet P. Report of the Canadian Hypertension Consensus Conference: 5, hypertension and diabetes. Can MedAssocJ. 1993;149:821-826.
  7. National High Blood Pressure Education Program Working Group. Working group report on hypertension and chronic renal failure. Arch Intern Med. 1991;151:1280-1287.
  8. Harris MI, Entmacher PS. Mortality from diabetes. In: Harris MI, Hamman RF, eds. Diabetes in America. Washington, DC: GPO; US Dept of Health and Human Services, NIH publication 85-1468; 1985:1-48.
  9. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program, I: reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA. 1979;242: 2562-2571.
  10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
  11. Dyken ML, Wolf PA, Barnett HJM, Bergan JJ, Hass WK, Kannel WB, Kuller L, Kurtzke JF, Sundt TM. Risk factors in stroke: a statement for physicians by the Subcommittee on Risk Factors and Stroke of the Stroke Council. Stroke. 1984;15:1105-llll.
  12. Glaucoma, Lens and Anterior Segment Trauma. San Francisco, Calif: American Academy of Ophthalmology; 1991:60.
  13. Bunzell JD, Chait A. Lipoprotein pathophysiology and treatment. In Rif kin H, Porte D, eds. Diabetes Mellitus Theory and Practice. New York, NY: Elsevier; 1990:756-767.
  14. Kolterman IG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity. J Clin Invest. 198O;65: 1272-1284.
  15. Barron WM. Hypertension. In: Barren WM, Lindheimer MD, eds. Medical Disorders in Pregnancy. Chicago, 111: Mosby-Year Book; 1991:1-42.
  16. National High Blood Pressure Education Program Working Group. Working group report on primary prevention of hyper- tension. Arch Intern Med. 1993;153:186-208.

Cited by

Sorted by citations

Related

Venue
Hypertension
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
1994-02
Volume
23
Issue
2
Pages
145-158
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
DOI
10.1161/01.hyp.23.2.145
OpenAlex
W2566199751
Cited by
1,004
References
98
Citations by year
2025: 3 · 2024: 5 · 2023: 1 · 2022: 6 · 2021: 6 · 2020: 9 · 2019: 13 · 2018: 13 · 2017: 13 · 2016: 15 · 2015: 25 · 2014: 44 · 2013: 47 · 2012: 56
FWCI
35.32
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Brigham and Women's Hospital
  • University of Southern California
  • Wayne State University
  • Georgetown University
  • Morehouse School of Medicine
  • National Institutes of Health
  • University of California, Los Angeles
  • School of Medicine, Indiana University
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Division of Diabetes, Endocrinology, and Metabolic Diseases
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
diabetes mellitus, hypertension in diabetes, antihypertensive drugs, lifestyle modification, pediatric diabetes, sexual dysfunction, target organ damage, kidney disease, cardiovascular disease, treatment algorithm, socioeconomic disparities
MeSH terms
Diabetes Mellitus, Female, Health Education, Humans, Hypertension, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review